HBP.TO
Helix Biopharma Corp
Price:  
0.17 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO Relative Valuation

0.4%
Upside

As of 2024-02-25, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is 0.17 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.17 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is 0.4%.

The range of the Relative Valuation is 0.17 - 0.17 CAD.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples -4.9x - -4.9x -4.9x
Fair Price 0.17 - 0.17 0.17
Upside 0.4% - 0.4% 0.4%
0.17 CAD
Stock Price
0.17 CAD
Fair Price

HBP.TO Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 -4.88
2024-02-22 -4.88
2024-02-21 -5.17
2024-02-20 -5.17
2024-02-16 -4.88
2024-02-15 -4.88
2024-02-13 -5.17
2024-02-12 -5.17
2024-02-09 -4.88
2024-02-07 -5.17
2024-02-06 -4.88
2024-02-05 -5.46
2024-02-02 -5.60
2024-01-31 -5.46
2024-01-29 -5.74
2024-01-26 -5.17
2024-01-24 -6.18
2024-01-23 -5.74
2024-01-22 -5.74
2024-01-19 -5.74
2024-01-16 -6.18
2024-01-15 -6.32
2024-01-12 -6.61
2024-01-11 -5.31
2024-01-08 -6.46
2024-01-03 -6.46
2024-01-02 -4.88
2023-12-29 -6.03
2023-12-28 -6.03
2023-12-27 -6.03
2023-12-21 -6.03
2023-12-20 -6.03
2023-12-19 -6.03
2023-12-18 -6.03
2023-12-15 -6.03
2023-12-12 -6.18
2023-12-07 -6.61
2023-12-06 -6.61
2023-12-05 -6.61
2023-12-04 -6.18
2023-12-01 -6.61
2023-11-30 -6.61
2023-11-28 -6.61
2023-11-27 -6.61